Eli Lilly and Co
NYSE:LLY

  • LAST PRICE
    877.7900
  • TODAY'S CHANGE (%)
    -31.5300 (-3.4674%)
  • Bid / Lots
    876.0000/ 6
  • Ask / Lots
    877.7000/ 1
  • Open / Previous Close
    893.6200 / 909.3200
  • Day Range
    875.6100
    901.2100
  • 52 Week Range
    516.5700
    972.5300
  • Volume
    4,377,346

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 1 hour ago by Dow Jones
      Companies Mentioned: LLY, RVMD, IPSC, GPCR

      In the event of a Republican victory, the tone could change in two ways: The mergers-and-acquisitions landscape could be more fluid and affable compared with the past four years. That won't benefit healthcare more than other sectors, but healthcare is a leader in consolidation. The biotech industry would be an obvious beneficiary. And, given that two pharma companies are closing in on a trillion dollars of enterprise value and UnitedHealth is six times as big as most peers, we could set the stage for a merger of equals, which hasn't been discussed in this industry for years.

    • 1 hour ago by Dow Jones
      Companies Mentioned: DXCM, LLY, NVO, AAPL, ABT

      Two weeks of wearing DexCom's patch-size Stelo glucose-monitoring device was a revelation. Who knew that I'd have to give up grapes? By Bill Alpert

      I survived 68 years without knowing my blood sugar levels. Ignorance is sweet.

    • 1 hour ago by Dow Jones
      Companies Mentioned: LLY, RVMD, IPSC, GPCR

      In the event of a Republican victory, the tone could change in two ways: The mergers-and-acquisitions landscape could be more fluid and affable compared with the past four years. That won't benefit healthcare more than other sectors, but healthcare is a leader in consolidation. The biotech industry would be an obvious beneficiary. And, given that two pharma companies are closing in on a trillion dollars of enterprise value and UnitedHealth is six times as big as most peers, we could set the stage for a merger of equals, which hasn't been discussed in this industry for years.

    • 7 hours ago by Dow Jones
      Companies Mentioned: LLY, RVMD, IPSC, GPCR

      In the event of a Republican victory, the tone could change in two ways: The mergers-and-acquisitions landscape could be more fluid and affable compared with the past four years. That won't benefit healthcare more than other sectors, but healthcare is a leader in consolidation. The biotech industry would be an obvious beneficiary. And, given that two pharma companies are closing in on a trillion dollars of enterprise value and UnitedHealth is six times as big as most peers, we could set the stage for a merger of equals, which hasn't been discussed in this industry for years.

  • Sep 25, 2024

Peers Headlines